KPTI
Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Healthcare
Karyopharm Therapeutics Inc. annual/quarterly long term debt history from 2021 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Karyopharm Therapeutics Inc. long term debt for the quarter ending December 31, 2021 were 169.3M.
- Karyopharm Therapeutics Inc. long term debt for 2021 were 169.3M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Karyopharm Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $169 |
| Karyopharm Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2021-12-31 | $169 |
Karyopharm Therapeutics Inc. Long Term Debt — FAQ
Karyopharm Therapeutics Inc. (KPTI) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPTI's long term debt history?
The chart and table above show Karyopharm Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.